induces increased glomerular permeability to albumin. While both the biochemical characteristics and evenBackground. Focal segmental glomerulosclerosis (FSGS ) aetiology remains undefined although a tual targets of this factor remain unknown, it should reflect a disorder of lymphocyte function, most derangement of lymphocytes and monocytes-macrophages, at least, has been strongly suspected. We report probably of T lymphocytes [2]. Saito and Atkins reported an increased number of monocytes-macrothe graft-infiltrating phenotypes and their cytokine production in a case of FSGS recurrence post-phages and lymphocytes in the interstitium throughout the evolution of experimental FSGS [3]. transplantation.
Subject and methods
Biopsy cultures pointed to a Th 0 /Th 1 pattern of cytokine production as well as significant synthesis of transforming growth factor-b 1.
Interestingly, mono-The patient presented with nephrotic syndrome when he was 33 years old, and renal biopsy showed FSGS. He was treated cyte chemokines were absent.
with oral steroids without any success, and reached end-
Conclusion.
We report evidence of intragraft lymphostage renal failure 5 years later, still suffering from unremitcyte activation in the early days of FSGS recurrence.
ting nephrotic proteinuria. He was started on regular Aspiration biopsy cultures showed failure of cyclospohaemodialysis and, 11 months later, he received a cadaver rin A to inhibit interleukin-2 (IL-2) production by renal transplant. Donor and recipient HLA were infiltrating lymphocytes. If our findings are confirmed A2,  in similar patients, a trial with anti-IL-2-receptor anti-respectively. The patient was treated from the beginning with body could be warranted.
Introduction
days 7 and 14 post-surgery. The samples were aspirated into 6 ml of RPMI medium with 125 U/ml of lithium heparin. A Focal segmental glomerulosclerosis ( FSGS) recurs in 500 ml aliquot was submitted to a brief cytocentrifugation 20-40% of patients receiving a first kidney transplant, and, after staining by a modified Romanowski method, GIL with ensuing graft failure in half of them [1] . In a were classified as described [8] .
One ml of each sample was analysed by flow cytometry recent paper, Savin et al.
[1] described a circulating using a FACScan from Becton-Dickinson@ as was the corresfactor in serum from recurrent FSGS patients which ponding peripheral blood sample; monoclonal antibodies were purchased from Coultar@ and Becton-Dickinson@. also tested for IL-2 and IL-10. After 96 h of incubation, cells were aspirated from the wells and, following a brief cytocentrifugation, they were stained by a modified Romanowski method. Trough blood cyclosporin levels were measured by a monoclonal TDx@ assay from Abbott. The patient gave his was evaluated for IL-2, IL-4, IL-10 and IFNc; the informed consent and this study is part of a research project values measured were 381, 0, 8 and 0 pg/ml, respectapproved by local Ethics Committee.
ively. From the day 14 aspiration biopsy culture supernatant, we confirmed a very high value for IL-2, 1188 pg/ml, curiously followed by a small increase in
Results
IL-10, 24 pg/ml. We also measured small amounts (pg/ml ) of IL-1ra, 30; IL-4-sRa, 6; IL-8, 263; and IL-12, 4. TGF-b 1 increased to 780 pg/ml, but TGF-b 2 A second core renal transplant biopsy carried out in was not present. Interestingly, we did not find any the fifth week post-transplantation showed FSGS.
trace of IL-6, GM-CSF, M-CSF or MIP-1a, and IL-4 Electron microscopy of the first biopsy evidenced meswas also absent. angial enlargement and effacement of visceral cell foot processes.
Serum creatinine on days 7 and 14 was 2.0 and Discussion 2.3 mg/dl, respectively, and blood cyclosporin levels were 223 and 250 gg/ml. Both fine-needle aspiration biopsies were classified Our patient suffered an early recurrence of FSGS posttransplantation. ( The recipient of the other kidney of as grade III, i.e. a borderline probability of rejection; no blasts were seen. Proliferation results on days 7 and this pair is enjoying good graft function without any abnormalities in urinary sediment.) The first core renal 14 were (median±SEM ) 1116±100.4 and 299±64.2 c.p.m., respectively. biopsy done on day 14 failed to provide enough tissue for analysis by light microscopy, but electron At the end of 96 h of incubation, on light microscopy, the day 7 culture displayed well preserved renal microscopy showed expansion of the mesangial area.
The second core renal biopsy at 5 weeks postcells and blast transformation in 10% of lymphocytes; no macrophages were seen. Day 14 culture did not transplantation displayed a full-blown FSGS picture.
As our patient has been free of any rejection episode show signs of lymphocyte activation, and half of the kidney cells exhibited mild to moderate vacuolization. for the first 9 months post-transplantation, we believe that our findings on graft-infiltrating lymphocytes, In Table 1 , we present the cytofluorometric analysis of T subsets present in FNAB samples and in peri-unlike what we have reported in stable kidney transplant recipients [6 ], may reflect mainly changes pheral blood lymphocytes (PBL). While the markers identifying early T cell activation were highly expressed brought about by FSGS recurrence.
Flow cytometry analysis showed signs of intraon FNAB T cells, DR expression ( late activation marker) on CD3 and CD8 subsets, which has shown graft activation, manifested by high expression of CD3CD25, CD3CD71, CD3CD69 and CD2CD54, at to correlate with acute rejection [6 ] , was present at the same order of magnitude as in a large group of stable the peripheral blood level this was less clear, as expression of CD3CD69 and CD3CD71 was considerkidney transplant patients previously analysed by us [6 ] . Interestingly, CD4CD29 expression on GIL was ably lower. While our patient presented low expression of CD3CD71 at the periphery, it was expressed prominent by day 14.
On day 7, circulating IL-2/IL-10 were 0/8 pg/ml; on in 39% of intragraft lymphocytes. This is one of the highest values we have observed; in a group of 52 day 14 they were 0/24 pg/ml, respectively.
The first week aspiration biopsy culture supernatant stable renal transplant patients, CD3CD71 expression Graft-infiltrating lymphocytes in FSGS recurrence post-transplantation 715 was found in 7.5±6.2% of cells [6 ] . Also, CD4CD29, mented 32% for FNAB CD2CD54 on day 7, compared with 19±16.4% found in 51 stable patients which identifies memory T cells, showed much higher expression on FNAB T cells from our patient on day previously studied [6 ] . The high value measured for TGF-b 1 could reflect the initiation of fibrogenesis [12] 14 compared with what we found in stable patients (26±10.8) [6 ] . This could reflect expansion of although cyclosporin A is thought to be a stimulant of TGF-b 1 synthesis. memory T cell clones specifically engaged in FSGS recurrence. On the other hand, we previously have
The proliferation results, much higher on day 7 than on day 14, probably reflect two phases, a dividing defined an activation score for GIL studied by flow cytometry that enabled us to differentiate between mode followed by a synthetic phase. Actually, the proliferation measured on day 7 is within the values stable vs acutely rejecting renal transplant recipients [6 ] . This score is based on FNAB T cell subsets that found in 28 patients with acute rejection, 1374±108 c.p.m.
[4], which we regard as another indirect sign of change most during an acute rejection crisis and it is obtained as the sum of the percentage of phenotypes GIL activation. Alternatively, this could reflect the start of monocyte-macrophage proliferation involved multiplied by empiric coefficients: DR×8 plus CD8DR×32 plus CD3DR×16 plus CD8CD57×4 in the early phases of FSGS [3] .
In summary, we describe an FSGS recurrence in the plus the ratio FNAB/PBL CD3CD25×40 plus FNAB/PBL CD3DR×100 minus CD4CD45RA×4 first 2 weeks post-surgery in a kidney transplant patient. As far as we are aware, this is the first report (this subset is significantly down-regulated during acute rejection). This activation score reaches a of clear signs of intragraft lymphocyte activation during the early days of FSGS recurrence postsensitivity of 83.9% and a specificity of 90.5% for acute rejection using a cut-off of 630 points [6 ] . With transplantation with a strong IL-2 production, although cultures also showed IL-10. An enhancement regard to our patient, this score reached 478 points on day 7 and came down to zero on day 14 post-of GIL CD4CD29 expression was seen on day 14, probably reflecting specific memory T cell clones transplantation, both well below the cut-off value for acute rejection, thus suggesting that different T subsets involved in the process. Altogether, our findings could mark the involvement of lymphocytes on the procedure were involved in this FSGS recurrence compared with acute rejection, namely CD3DR and CD8DR, both escaping cyclosporin A immunosuppressive ( IL-2 inhibition) effects. Furthermore, we measured importsignificantly up-regulated during rejection [6 ] .
Cytokine analysis of serum showed the absence of ant TGF-b 1 synthesis that could well be associated with early fibrinogenesis. Provided a future study involcirculating IL-2 and a small amount of IL-10, which is in agreement with previous observations in a group ving more FSGS recurrence cases confirms that a IL-2 rise is both involved in early stages of recurrence and, of 43 transplant patients [7] . On the contrary, there was a significant production of IL-2 by aspiration at the same time, constitutes a marker of the inability of cyclosporin A to suppress lymphocyte response, a biopsy cultures. Actually, both IL-2 values, measured from day 7 and day 14 samples were >250 pg/ml, trial with anti-IL-2-receptor antibody could be warranted. which according to our experience is a reliable cut-off value for acute rejection crisis in kidney transplants reaching 100% sensitivity and 87.2% specificity [7] .
